Actylis Acquires Pharm-Rx, a Leading Value-Added Supplier of Specialty Ingredients for the Vitamin, Mineral, and Supplement and Pharmaceutical Industries

—Brings 30+ Years of Leadership In Value-Added Services and Products for the VMS and OTC Pharmaceutical Industries—

—Expands Actylis’ Nutraceuticals Capabilities and Complements Its Growing Life Sciences Industry Presence—

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Actylis, a provider of choice for life sciences and advanced technology specialty ingredients, today announced the strategic acquisition of Pharm-Rx, a leading value-added supplier of specialty ingredients for the vitamin, mineral, and supplement (“VMS”) and pharmaceutical industries. The Pharm-Rx acquisition significantly enhances Actylis’ ability to deliver exceptional value to its customers, increases its range of solutions for clients, and strengthens its strategic supplier partnerships to enhance its innovative portfolio and service offerings. Pharm-Rx’s strong team and industry expertise broadens Actylis’ capabilities to help accelerate growth with nutrition and over-the-counter (OTC) pharmaceutical customers. Additionally, current President & Head of Business Development for Pharm-Rx, Mark Bostel, will be assuming the role of President, Global Nutrition and OTC for Actylis, leading both Pharm-Rx and Actylis’ Nutrition and OTC businesses.

For more than 30 years, Saddle Brook, NJ-based Pharm-Rx has been a leading supplier of active ingredients to the VMS, OTC, and prescription pharmaceutical markets. The company is well known for its customer-centric approach, providing difficult-to-find specialty ingredients from premier manufacturers globally. Pharm-Rx has developed industry-leading expertise in addressing customer needs, overcoming regulatory hurdles, and navigating international logistics complexities.

Scott Thomson, Actylis CEO, said, "We are thrilled to welcome Pharm-Rx into the Actylis family. This acquisition is a significant milestone in our growth strategy, allowing us to offer even greater value to our customers through an expanded portfolio and enhanced capabilities and expertise. By leveraging our combined strengths, we are poised to deliver the most innovative solutions to meet the ever-evolving needs of the markets that we serve. We are excited to welcome Mark Bostel to the Actylis leadership team and work together to drive accelerated growth for our combined nutrition and OTC business in partnership with our customers.”

Mark Bostel added, "Pharm-Rx found the ideal partner in Actylis - their strengths perfectly align with ours. It is clear that together, we can offer our suppliers broader access to clients globally while expanding our differentiated product offerings to our loyal and growing customer base. We are most excited about the complementary nature of our businesses, positioning us to better serve our markets and unlock new opportunities."

Pharm-Rx will continue to operate under its current brand within Actylis and be led by the current management team including Mark Bostel, Carlos Doussinague, and Ann Smith.

Alantra and Adams and Reese LLP advised Pharm-Rx on the transaction. UB Greensfelder LLP advised Actylis. Financial terms of the transaction were not disclosed.

About Actylis

Actylis is a provider of choice for differentiated specialty ingredients in the life sciences and advanced technology end markets. With business operations in 10 countries, Actylis manufactures and supplies more than 3,000 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries. In the last four years, Actylis has completed eight acquisitions, which have expanded its manufacturing, R&D, and portfolio offerings, transforming the company into a worldwide supplier of critical ingredients with a robust manufacturing footprint. Actylis’ global operations, including a significant presence on the ground in China, India, Europe and North America, enable the company’s deep worldwide sourcing and regulatory capabilities. Actylis is well positioned to drive new innovative solutions, ensure quality and customize products to meet customers’ specific needs. For more information visit Actylis.com.

About Pharm-Rx

Pharm-Rx, founded in 1991, is a global supplier of nutritional, active pharmaceutical, and other specialty ingredients. Pharm-Rx collaborates with a worldwide network of suppliers to serve its customer base of major contract manufacturers and branded companies. Its commitment is to build long-term business relationships through quality ingredients, competitive pricing, and exceptional customer service. Pharm-Rx connects vendors with its extensive network of leading brands and manufacturers, enhancing market presence and penetration. The company focuses on offering innovative solutions from domestic and international markets including Asia, Africa, Europe, and South America for both nutritional and pharmaceutical products.